Genovis AB (publ.) Statistics

Total Valuation

STO:GENO has a market cap or net worth of SEK 1.73 billion. The enterprise value is 1.64 billion.

Market Cap	1.73B
Enterprise Value	1.64B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:GENO has 66.06 million shares outstanding.

Current Share Class	66.06M
Shares Outstanding	66.06M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.60%
Owned by Institutions (%)	51.67%
Float	56.42M

Valuation Ratios

The trailing PE ratio is 63.63 and the forward PE ratio is 53.17. STO:GENO's PEG ratio is 1.33.

PE Ratio	63.63
Forward PE	53.17
PS Ratio	14.05
PB Ratio	7.25
P/TBV Ratio	7.81
P/FCF Ratio	73.18
P/OCF Ratio	70.44
PEG Ratio	1.33

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.16, with an EV/FCF ratio of 69.49.

EV / Earnings	60.97
EV / Sales	13.34
EV / EBITDA	45.16
EV / EBIT	62.40
EV / FCF	69.49

Financial Position

The company has a current ratio of 12.69, with a Debt / Equity ratio of 0.34.

Current Ratio	12.69
Quick Ratio	10.17
Debt / Equity	0.34
Debt / EBITDA	2.26
Debt / FCF	3.45
Interest Coverage	6.13

Financial Efficiency

Return on equity (ROE) is 12.08% and return on invested capital (ROIC) is 5.37%.

Return on Equity (ROE)	12.08%
Return on Assets (ROA)	5.10%
Return on Invested Capital (ROIC)	5.37%
Return on Capital Employed (ROCE)	8.19%
Revenue Per Employee	3.62M
Profits Per Employee	792,853
Employee Count	32
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

In the past 12 months, STO:GENO has paid 10.52 million in taxes.

Income Tax	10.52M
Effective Tax Rate	28.06%

Stock Price Statistics

The stock price has decreased by -11.25% in the last 52 weeks. The beta is 1.88, so STO:GENO's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	-11.25%
50-Day Moving Average	27.09
200-Day Moving Average	24.86
Relative Strength Index (RSI)	39.05
Average Volume (20 Days)	62,877

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:GENO had revenue of SEK 123.19 million and earned 26.96 million in profits. Earnings per share was 0.41.

Revenue	123.19M
Gross Profit	109.35M
Operating Income	26.00M
Pretax Income	37.47M
Net Income	26.96M
EBITDA	29.58M
EBIT	26.00M
Earnings Per Share (EPS)	0.41

Full Income Statement

Balance Sheet

The company has 168.99 million in cash and 81.58 million in debt, giving a net cash position of 87.41 million or 1.32 per share.

Cash & Cash Equivalents	168.99M
Total Debt	81.58M
Net Cash	87.41M
Net Cash Per Share	1.32
Equity (Book Value)	238.82M
Book Value Per Share	3.65
Working Capital	194.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.57 million and capital expenditures -921,000, giving a free cash flow of 23.65 million.

Operating Cash Flow	24.57M
Capital Expenditures	-921,000
Free Cash Flow	23.65M
FCF Per Share	0.36

Full Cash Flow Statement

Margins

Gross margin is 88.76%, with operating and profit margins of 21.10% and 21.88%.

Gross Margin	88.76%
Operating Margin	21.10%
Pretax Margin	30.42%
Profit Margin	21.88%
EBITDA Margin	24.02%
EBIT Margin	21.10%
FCF Margin	19.20%

Dividends & Yields

STO:GENO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.56%
FCF Yield	1.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 4, 2012
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	5